首页> 外文OA文献 >Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy

【2h】

Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy

机译：下一代流式细胞术在多个骨髓瘤患者中持续完全缓解前的下一代流式细胞术对持续完全缓解的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Evangelos Terpos; Ioannis V. Kostopoulos; Efstathios Kastritis; Ioannis Ntanasis-Stathopoulos; Magdalini Migkou; Pantelis Rousakis; Alexandra T. Argyriou; Nikolaos Kanellias; Despina Fotiou; Evangelos Eleutherakis-Papaiakovou; Maria Gavriatopoulou; Dimitrios C. Ziogas; Aristea-Maria Papanota; Marilyn Spyropoulou-Vlachou; Ioannis P. Trougakos; Ourania E. Tsitsilonis; Bruno Paiva; Meletios A. Dimopoulos;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 22:01:23

相似文献

外文文献
中文文献
专利

1. Comparison of Minimal Residual Disease Detection in Autografts of Patients with Multiple Myeloma between 8-Color Multiparameter Flow Cytometry (EuroFlow) and Next-Generation Sequencing [J] . Takamatsu Hiroyuki, Takezako Naoki, Wee Rachel K., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：8色多次髓瘤患者自体移植患者的最小残留疾病检测比较（EUROFLOW）和下一代测序
2. Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation [J] . Hiroyuki Takamatsu Journal of Clinical Medicine . 2017,第10期

机译：自体干细胞移植多发性骨髓瘤患者通过多参数流式细胞术，ASO-qPCR，液滴数字PCR和深度测序进行最小残留疾病检测的比较
3. Minimal Residual Disease Evaluation Using 8-Color Flow Cytometry Predicts Risk of Relapse in High-Risk and/or Young Myeloma Patients Who Receive Bortezomib Consolidation after Frontline Tandem Transplantation [J] . Leblanc Richard, Ahmad Imran, Terra Rafik, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：使用8色流式细胞术的最小残留疾病评估预测了在前线串联移植后获得硼佐米菌的高风险和/或年轻骨髓瘤患者复发的风险
4. Measuring Minimal Residual Disease in Multiple Myeloma by LC-MS/MS; A Comparison to Multicolor Flow Cytometry [C] . H. Robert Bergen, Angela Dispenzieri, Surendra Dasari, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：通过LC-MS / MS测量多发性骨髓瘤中的最小残留疾病;与多色流式细胞术的比较
5. Detection and Monitoring of Multiple Myeloma Measurable Residual Disease by High Sensitivity Flow Cytometry [D] . Soh, Kah Teong. 2020

机译：高灵敏度流式细胞术检测和监测多发性骨髓瘤可测量的残留疾病
6. Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy [O] . Evangelos Terpos, Ioannis V. Kostopoulos, Efstathios Kastritis, 2019

机译：新一代流式细胞术检测最小残留疾病对一线治疗后持续完全缓解的多发性骨髓瘤患者的影响
7. Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation [O] . Hiroyuki Takamatsu 2017

机译：自体干细胞移植多发性骨髓瘤患者多参数流式细胞仪，asO-qpCR，液滴数字pCR和深度测序检测微小残留病的比较

Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy

著录项

相似文献

相关主题

期刊订阅